Potential Side Effects Of Prostate Removal
To treat potentially deadly prostate cancer, the surgical removal of the prostate is sometimes necessary. The procedure can have potential side effects, including a shortened penis.
Spike in Protein Flags Cancer Growth
High levels of certain proteins appear to stimulate tumor growth. Newly discovered proteins can help doctors identify patients who are at increased risk for aggressive prostate cancer.
Men Have Hormonal Blues Too
Most prostate cancers are fed by male hormones called androgens. So treating the disease often involves blocking these hormones. It’s called androgen deprivation therapy (ADT), and it’s been used for decades – but not without controversy.
More Life. Less Pain. Cancer Rx Delivers Both.
Zytiga ( abiraterone acetate) received expanded use approval to treat men with advanced prostate cancer last week. In addition to extending lives, a new study has found Zytiga also keeps men feeling better during their journey.
Advanced Prostate Cancer Rx Being Reviewed
Men with metastatic prostate cancer may have a new treatment. Radium-223 dichloride (radium-223) is designed to treat castration-resistant prostate cancer that has spread to the bone.
Drug May Reduce Cancer Spread to Bone
Patients with advanced prostate cancer may have cancer cells that spread to the bone and cause pain. A new drug shows promise by rapidly reducing prostate cancer bone tumors.
New Option For Late-Stage Prostate Cancer
Men with castration-resistant prostate cancer have another treatment option. The US Food and Drug Administration (FDA) has approved the expanded use of Zytiga (abiraterone acetate).
Does Red Wine Fight Prostate Cancer?
You may have heard that a glass of red wine a day is good for your heart. Research now shows that the beneficial compound found in red wine may also help fight prostate cancer.
Phase I Success for new Prostate Cancer Drug
For men with aggressive prostate cancer, few treatment options are available. A new drug, however, showed a positive effect in reducing the number of tumor cells and cancer markers in advanced prostate cancer.
Early Prostate Screenings May Not Be Worth It
Prostate cancer is the most common non-skin cancer in men. While some specialty organizations recommend that screening begin at age 40, there is little evidence showing real benefits to screening at this age.